Matches in SemOpenAlex for { <https://semopenalex.org/work/W1541614540> ?p ?o ?g. }
- W1541614540 endingPage "560" @default.
- W1541614540 startingPage "551" @default.
- W1541614540 abstract "Interim 2-[18F]Fluoro-2-deoxy-D-glucose Positron Emission Tomography performed after two chemotherapy cycles (PET-2) is the most reliable predictor of treatment outcome in ABVD-treated Hodgkin Lymphoma (HL) patients. We retrospectively analysed the treatment outcome of a therapeutic strategy based on PET-2 results: positive patients switched to BEACOPP, while negative patients continued with ABVD. Between January 2006 and December 2007, 219 newly diagnosed HL patients admitted to nine centres were enrolled; 54 patients, unfit to receive this treatment were excluded from the analysis. PET-2 scans were reviewed by a central panel of nuclear medicine experts, according to the Deauville score (Meignan, 2009). After a median follow up of 34 months (12-52) the 2-year failure free survival (FFS) and overall survival for the entire cohort of 165 patients were 88% and 98%; the FFS was 65% for PET-2 positive and 92% for PET-2 negative patients. For 154 patients in which treatment was correctly given according to PET-2 review, the 2-year FFS was 91%: 62% for PET-2 positive and 95% for PET-2 negative patients.this strategy, with BEACOPP intensification only in PET-2 positive patients, showed better results than ABVD-treated historic controls, sparing BEACOPP toxicity to the majority of patients." @default.
- W1541614540 created "2016-06-24" @default.
- W1541614540 creator A5003232812 @default.
- W1541614540 creator A5013717203 @default.
- W1541614540 creator A5013771260 @default.
- W1541614540 creator A5015840872 @default.
- W1541614540 creator A5025496065 @default.
- W1541614540 creator A5030934542 @default.
- W1541614540 creator A5038898384 @default.
- W1541614540 creator A5047187911 @default.
- W1541614540 creator A5049017377 @default.
- W1541614540 creator A5052597763 @default.
- W1541614540 creator A5055401685 @default.
- W1541614540 creator A5062765629 @default.
- W1541614540 creator A5063672889 @default.
- W1541614540 creator A5063715851 @default.
- W1541614540 creator A5065510950 @default.
- W1541614540 creator A5069410590 @default.
- W1541614540 creator A5083068356 @default.
- W1541614540 creator A5084921812 @default.
- W1541614540 creator A5087990801 @default.
- W1541614540 creator A5090432217 @default.
- W1541614540 date "2010-12-20" @default.
- W1541614540 modified "2023-10-17" @default.
- W1541614540 title "Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses" @default.
- W1541614540 cites W1504115866 @default.
- W1541614540 cites W1899858299 @default.
- W1541614540 cites W1973535185 @default.
- W1541614540 cites W1976281058 @default.
- W1541614540 cites W1989826112 @default.
- W1541614540 cites W2001292073 @default.
- W1541614540 cites W2010746974 @default.
- W1541614540 cites W2051650384 @default.
- W1541614540 cites W2053154970 @default.
- W1541614540 cites W2058383365 @default.
- W1541614540 cites W2066799536 @default.
- W1541614540 cites W2070725201 @default.
- W1541614540 cites W2105936879 @default.
- W1541614540 cites W2107069243 @default.
- W1541614540 cites W2115919161 @default.
- W1541614540 cites W2120470395 @default.
- W1541614540 cites W2123026782 @default.
- W1541614540 cites W2126823640 @default.
- W1541614540 cites W2133201432 @default.
- W1541614540 cites W2133260927 @default.
- W1541614540 cites W2134963351 @default.
- W1541614540 cites W2136962826 @default.
- W1541614540 cites W2137965731 @default.
- W1541614540 cites W2148788579 @default.
- W1541614540 cites W2158248786 @default.
- W1541614540 cites W2159317665 @default.
- W1541614540 cites W2162340856 @default.
- W1541614540 cites W2164777277 @default.
- W1541614540 cites W2165308914 @default.
- W1541614540 cites W2328676772 @default.
- W1541614540 cites W2329725057 @default.
- W1541614540 cites W3147894994 @default.
- W1541614540 cites W4293241248 @default.
- W1541614540 doi "https://doi.org/10.1111/j.1365-2141.2010.08485.x" @default.
- W1541614540 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21166786" @default.
- W1541614540 hasPublicationYear "2010" @default.
- W1541614540 type Work @default.
- W1541614540 sameAs 1541614540 @default.
- W1541614540 citedByCount "123" @default.
- W1541614540 countsByYear W15416145402012 @default.
- W1541614540 countsByYear W15416145402013 @default.
- W1541614540 countsByYear W15416145402014 @default.
- W1541614540 countsByYear W15416145402015 @default.
- W1541614540 countsByYear W15416145402016 @default.
- W1541614540 countsByYear W15416145402017 @default.
- W1541614540 countsByYear W15416145402018 @default.
- W1541614540 countsByYear W15416145402019 @default.
- W1541614540 countsByYear W15416145402020 @default.
- W1541614540 countsByYear W15416145402021 @default.
- W1541614540 countsByYear W15416145402022 @default.
- W1541614540 countsByYear W15416145402023 @default.
- W1541614540 crossrefType "journal-article" @default.
- W1541614540 hasAuthorship W1541614540A5003232812 @default.
- W1541614540 hasAuthorship W1541614540A5013717203 @default.
- W1541614540 hasAuthorship W1541614540A5013771260 @default.
- W1541614540 hasAuthorship W1541614540A5015840872 @default.
- W1541614540 hasAuthorship W1541614540A5025496065 @default.
- W1541614540 hasAuthorship W1541614540A5030934542 @default.
- W1541614540 hasAuthorship W1541614540A5038898384 @default.
- W1541614540 hasAuthorship W1541614540A5047187911 @default.
- W1541614540 hasAuthorship W1541614540A5049017377 @default.
- W1541614540 hasAuthorship W1541614540A5052597763 @default.
- W1541614540 hasAuthorship W1541614540A5055401685 @default.
- W1541614540 hasAuthorship W1541614540A5062765629 @default.
- W1541614540 hasAuthorship W1541614540A5063672889 @default.
- W1541614540 hasAuthorship W1541614540A5063715851 @default.
- W1541614540 hasAuthorship W1541614540A5065510950 @default.
- W1541614540 hasAuthorship W1541614540A5069410590 @default.
- W1541614540 hasAuthorship W1541614540A5083068356 @default.
- W1541614540 hasAuthorship W1541614540A5084921812 @default.
- W1541614540 hasAuthorship W1541614540A5087990801 @default.
- W1541614540 hasAuthorship W1541614540A5090432217 @default.
- W1541614540 hasBestOaLocation W15416145401 @default.